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With the instigation of population screening strategies
to reduce the burden of colorectal cancer, a cost effec-
tive approach remains an elusive goal. Genetic markers
associated with colorectal cancer have the potential to
be used for the early identification of patient groups at
elevated risk of disease. The choice of genetic markers
that can be used for screening purposes is population
specific.
In this report we have genotyped 3059 individuals for 13
markers that have been associated with colorectal cancer
risk. The participants underwent colonoscopy and controls
with clear colonoscopy (1838) were compared to cases
with advanced colorectal neoplasia (213). Logistic regres-
sion analysis, adjusted for sex and age at colonoscopy,
showed that only one of the markers (rs4779584) was sig-
nificantly associated with the risk of advanced colorectal
neoplasia (OR = 1.93; 95% CI = 1.22 – 2.99; p-value =
0.004; sensitivity = 20%). A combination of 7 markers
(rs4779584, rs2578187, rs3802842, rs6983267, NOD2
5020insC, rs4464148 and rs4939827) showed an optimal
trade-off minimizing the number of markers considered,
while maximizing the relative size of the carrier group and
the risk associated to it (e.g. for at least 4 cumulated risk
markers, OR = 4.23; 95% CI = 1.5 – 10.4; p-value =
0.0036; sensitivity = 4.7%). For this combination of 7 mar-
kers the linear cumulative risk model was statistically sig-
nificant (p=7.0·10-5) after adjustment for sex and age at
colonoscopy.
The identification of such cumulative models could be
valuable in better defining a group of persons, within a
given population, that are most likely to benefit from
screening for colorectal cancer.
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